Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab

Aim: We previously reported a prospective trial evaluating the safety and efficacy of combining ipilimumab and radiation therapy in patients with metastatic melanoma. Herein, we provide a long-term update on patients with complete response (CR) or partial response (PR). Patients & methods: We co...

Full description

Bibliographic Details

Published in:	Melanoma Management
Main Authors:	Quaovi H Sodji, Paulina M Gutkin, Susan M Swetter, Sunil A Reddy, Susan M Hiniker, Susan J Knox
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-05-01
Subjects:	hypophysitis immunotherapy melanoma radiation therapy
Online Access:	https://www.futuremedicine.com/doi/10.2217/mmt-2019-0020